Skip to main content
Top
Published in: Clinical and Experimental Nephrology 3/2018

Open Access 01-06-2018 | Original article

Ionized and total serum magnesium in hemodialysis: predictors and variability. A longitudinal cross-sectional study

Authors: Rosaria Del Giorno, Hilary Riva, Gaetano Donato, Luca Gabutti

Published in: Clinical and Experimental Nephrology | Issue 3/2018

Login to get access

Abstract

Background

Ionized Magnesium (ion-Mg) represents the active biological fraction of the serum magnesium content. The assessment of total serum Mg (tot-Mg) might not accurately identify patients with hypo-or hyper-magnesaemie. In hemodialysis, serum tot-Mg levels in the upper part of the distribution, have been associated with reduced mortality and fewer vascular calcifications; thus, resulting in the tendency to increase the Mg concentration in the dialysate, traditionally set at 0.5 mmol/L.

Methods

Single-center study in chronic hemodialysis patients, designed in two phases, cross-sectional and longitudinal, aimed to investigate: (1) the sensitivity for pathological values of ion-Mg compared to tot-Mg (2) the predictors of ion-Mg developing ad hoc equations; (3) the inter- and intra-individual variabilities of ion-Mg; and (4) the risk factors for hypermagnesemia. Tot-Mg, ion-Mg, and covariates of 42 hemodialysis sessions, in 42 patients during the cross-sectional phase and of 270 sessions in 27 patients in the longitudinal one were analysed.

Results

Ion-Mg significantly correlates with tot-Mg: β = 0.52; r = 0.88, p < 0.001. Multiple linear regressions in normo- and hypo-albuminemic patients gave the following results: ion-Mg = tot-Mg/2-K+/50 + Ca2+/5-HCO3−/100 and ion-Mg = tot-Mg/2 + albumin/100. Ion-Mg showed a high temporal variability in the longitudinal phase (between months p < 0.001; winter vs. summer, p < 0.027). A high intra-individual variability was also found: coefficient of variation 0.116. Comparing patients with high and low intra-individual variability, we found: age 67 vs. 77 years; p < 0.001; urea 26.3 ± 0.5 vs. 21.2 ± 0.4 mmol/L, p < 0.001; nPCR 0.92 ± 0.1 vs. 0.77 ± 0.1 g/kg day, p < 0.001; PTH 46.3 ± 4 vs. 28.5 ± 3 pmol/L, p < 0.001.

Conclusions

Ion-Mg can be useful in unmasking unrecognized hyper- and hypo-magnesemic and false hyper-magnesemic patients. Ion-Mg is characterized by high intra- and inter-individual variabilities particularly in younger women and those with better nutrition. Patients with greater variability could potentially be at risk if exposed to higher concentrations of magnesium in the dialysate. An interventional study, with controlled increase of magnesium concentrations in the dialysate has been planned.
Literature
3.
go back to reference Elin RJ. Assessment of magnesium status for diagnosis and therapy. Magnes Res. 2010;23:194–8. Elin RJ. Assessment of magnesium status for diagnosis and therapy. Magnes Res. 2010;23:194–8.
4.
go back to reference Ryan MF. The role of magnesium in clinical biochemistry: an overview. Ann Clin Biochem. 1991;28:19–26.CrossRefPubMed Ryan MF. The role of magnesium in clinical biochemistry: an overview. Ann Clin Biochem. 1991;28:19–26.CrossRefPubMed
5.
go back to reference Spiegel DM. Magnesium in chronic kidney disease: unanswered questions. Blood Purif. 2011;31:172–6.CrossRefPubMed Spiegel DM. Magnesium in chronic kidney disease: unanswered questions. Blood Purif. 2011;31:172–6.CrossRefPubMed
6.
go back to reference Shechter M. Magnesium and cardiovascular system. Magnes Res. 2010;23:60–72.PubMed Shechter M. Magnesium and cardiovascular system. Magnes Res. 2010;23:60–72.PubMed
7.
8.
go back to reference Salem S, Bruck H, Bahlmann FH, et al. Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification. Am J Nephrol. 2012;35:31–9.CrossRefPubMed Salem S, Bruck H, Bahlmann FH, et al. Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification. Am J Nephrol. 2012;35:31–9.CrossRefPubMed
9.
go back to reference Louvet L, Bazin D, Büchel J, et al. Characterisation of calcium phosphate crystals on calcified human aortic vascular smooth muscle cells and potential role of magnesium. PLoS One. 2015;10(1):e0115342.CrossRefPubMedPubMedCentral Louvet L, Bazin D, Büchel J, et al. Characterisation of calcium phosphate crystals on calcified human aortic vascular smooth muscle cells and potential role of magnesium. PLoS One. 2015;10(1):e0115342.CrossRefPubMedPubMedCentral
10.
go back to reference Neven E, De Schutter TM, Dams G, et al. A magnesium based phosphate binder reduces vascular calcification without affecting bone in chronic renal failure rats. PLoS One. 2014;9(9):e107067.CrossRefPubMedPubMedCentral Neven E, De Schutter TM, Dams G, et al. A magnesium based phosphate binder reduces vascular calcification without affecting bone in chronic renal failure rats. PLoS One. 2014;9(9):e107067.CrossRefPubMedPubMedCentral
11.
go back to reference Ishimura E, Okuno S, Yamakawa T, et al. Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnes Res. 2007;20:237–44.PubMed Ishimura E, Okuno S, Yamakawa T, et al. Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnes Res. 2007;20:237–44.PubMed
12.
go back to reference Sakaguchi Y, Fujii N, Shoji T, et al. Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int. 2014;85:174–81.CrossRefPubMed Sakaguchi Y, Fujii N, Shoji T, et al. Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int. 2014;85:174–81.CrossRefPubMed
13.
go back to reference Lutsey PL, Alonso A, Michos ED, et al. Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr. 2014;100:756–64.CrossRefPubMedPubMedCentral Lutsey PL, Alonso A, Michos ED, et al. Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr. 2014;100:756–64.CrossRefPubMedPubMedCentral
14.
go back to reference Kyriazis J, Kalogeropoulou K, Bilirakis L, et al. Dialysate magnesium level and blood pressure. Kidney Int. 2004;66:1221–31.CrossRefPubMed Kyriazis J, Kalogeropoulou K, Bilirakis L, et al. Dialysate magnesium level and blood pressure. Kidney Int. 2004;66:1221–31.CrossRefPubMed
15.
go back to reference Filiopoulos V, Hadjiyannakos D, Vlassopoulos D. Optimal plasma and dialysate magnesium concentrations in hemodialysis patients: the unsettled issues. Am J Kidney Dis. 2016;67(2):341.CrossRefPubMed Filiopoulos V, Hadjiyannakos D, Vlassopoulos D. Optimal plasma and dialysate magnesium concentrations in hemodialysis patients: the unsettled issues. Am J Kidney Dis. 2016;67(2):341.CrossRefPubMed
16.
go back to reference Külpmann WR, Rössler J, Brunkhorst R, et al. Ionised and total magnesium serum concentrations in renal and hepatic diseases. Eur J Clin Chem Clin Biochem. 1996;34:257–64.PubMed Külpmann WR, Rössler J, Brunkhorst R, et al. Ionised and total magnesium serum concentrations in renal and hepatic diseases. Eur J Clin Chem Clin Biochem. 1996;34:257–64.PubMed
17.
go back to reference Alhosaini M, Leehey DJ. Magnesium and dialysis: the neglected cation. Am J Kidney Dis. 2015;66:523–31.CrossRefPubMed Alhosaini M, Leehey DJ. Magnesium and dialysis: the neglected cation. Am J Kidney Dis. 2015;66:523–31.CrossRefPubMed
18.
go back to reference Nakashima A, Ohkido I, Yokoyama K, Mafune A, Urashima M, Yokoo T. Proton pump inhibitor use and magnesium concentrations in hemodialysis patients: a cross-sectional study. PLoS One. 2015;10(11):e0143656.CrossRefPubMedPubMedCentral Nakashima A, Ohkido I, Yokoyama K, Mafune A, Urashima M, Yokoo T. Proton pump inhibitor use and magnesium concentrations in hemodialysis patients: a cross-sectional study. PLoS One. 2015;10(11):e0143656.CrossRefPubMedPubMedCentral
19.
go back to reference Dewitte K, Dhondt A, Giri M, Stöckl D, Rottiers R, Lameire N, Thienpont LM. Differences in serum ionized and total magnesium values during chronic renal failure between nondiabetic and diabetic patients: a cross-sectional study. Diabetes Care. 2004;27(10):2503–5.CrossRefPubMed Dewitte K, Dhondt A, Giri M, Stöckl D, Rottiers R, Lameire N, Thienpont LM. Differences in serum ionized and total magnesium values during chronic renal failure between nondiabetic and diabetic patients: a cross-sectional study. Diabetes Care. 2004;27(10):2503–5.CrossRefPubMed
20.
go back to reference Escuela MP, Guerra M, Anon JM, et al. Total and ionized serum magnesium in critically ill patients. Intensive Care Med. 2005;31:151–6.CrossRefPubMed Escuela MP, Guerra M, Anon JM, et al. Total and ionized serum magnesium in critically ill patients. Intensive Care Med. 2005;31:151–6.CrossRefPubMed
21.
go back to reference Saris NE, Mervaala E, Karppanen H, et al. Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta. 2000;294:1–26.CrossRefPubMed Saris NE, Mervaala E, Karppanen H, et al. Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta. 2000;294:1–26.CrossRefPubMed
22.
go back to reference Gonzalez-Revalderia J, Garcia-Bermejo S, Menchen-Herreros A, et al. Biological variation of Zn, Cu, and Mg in serum of healthy subjects. Clin Chem. 1990;36:2140–1.PubMed Gonzalez-Revalderia J, Garcia-Bermejo S, Menchen-Herreros A, et al. Biological variation of Zn, Cu, and Mg in serum of healthy subjects. Clin Chem. 1990;36:2140–1.PubMed
23.
go back to reference Truttmann AC, Faraone R, Von Vigier RO, et al. Maintenance hemodialysis and circulating ionized magnesium. Nephron. 2002;92:616–21.CrossRefPubMed Truttmann AC, Faraone R, Von Vigier RO, et al. Maintenance hemodialysis and circulating ionized magnesium. Nephron. 2002;92:616–21.CrossRefPubMed
24.
go back to reference Cunningham J, Rodríguez M, Messa P. Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients. Clin Kidney J. 2012;5(Suppl 1):i39–51.CrossRefPubMedPubMedCentral Cunningham J, Rodríguez M, Messa P. Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients. Clin Kidney J. 2012;5(Suppl 1):i39–51.CrossRefPubMedPubMedCentral
25.
go back to reference Dewitte K, Dhondt A, Lameire N, et al. The ionized fraction of serum total magnesium in hemodialysis patients: is it really lower than in healthy subjects? Clin Nephrol. 2002;58:205–10.CrossRefPubMed Dewitte K, Dhondt A, Lameire N, et al. The ionized fraction of serum total magnesium in hemodialysis patients: is it really lower than in healthy subjects? Clin Nephrol. 2002;58:205–10.CrossRefPubMed
26.
go back to reference Newhouse IJ, Johnson KP, Montelpare WJ, et al. Variability within individuals of plasma ionic magnesium concentrations. BMC Physiol. 2002;26(2):6.CrossRef Newhouse IJ, Johnson KP, Montelpare WJ, et al. Variability within individuals of plasma ionic magnesium concentrations. BMC Physiol. 2002;26(2):6.CrossRef
27.
go back to reference Nowell NW, White DC. Seasonal variation of magnesium and calcium in serum of the hypothermic rat. J Appl Physiol. 1963;18:967–9.CrossRefPubMed Nowell NW, White DC. Seasonal variation of magnesium and calcium in serum of the hypothermic rat. J Appl Physiol. 1963;18:967–9.CrossRefPubMed
28.
go back to reference Fein PA, Weiss S, Avram MM, et al. Relationship of normalized protein catabolic rate with nutrition status and long-term survival in peritoneal dialysis patients. Adv Perit Dial. 2015;31:45–8.PubMed Fein PA, Weiss S, Avram MM, et al. Relationship of normalized protein catabolic rate with nutrition status and long-term survival in peritoneal dialysis patients. Adv Perit Dial. 2015;31:45–8.PubMed
Metadata
Title
Ionized and total serum magnesium in hemodialysis: predictors and variability. A longitudinal cross-sectional study
Authors
Rosaria Del Giorno
Hilary Riva
Gaetano Donato
Luca Gabutti
Publication date
01-06-2018
Publisher
Springer Singapore
Published in
Clinical and Experimental Nephrology / Issue 3/2018
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-017-1494-6

Other articles of this Issue 3/2018

Clinical and Experimental Nephrology 3/2018 Go to the issue